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Abstract 
Both alterations to the epigenome and loss of polarity have been linked to cancer 
initiation, progression and metastasis. It has previously been demonstrated that loss 
of the epigenetic reader protein Kaiso suppresses intestinal tumourigenesis in the 
Apc+/min mouse model, in which altered polarity plays a key role.  Thus, we 
investigated the link between Kaiso deficiency, polarity and suppression of intestinal 
tumourigenesis. We used Kaiso deficient mice to conditionally delete Apc within the 
intestinal epithelia and demonstrated up-regulation of the spindle polarity genes Dlg1 
and Dlgap1. To understand the role of Dlg1 we generated Villin-creApc+/minDlg1flx/flx 
Kaiso-/y mice to analyse gene expression, survival, tumour burden and spindle 
orientation. In vivo analysis of the Dlg1 deficient intestine revealed improper 
orientation of mitotic spindles and a decreased rate of cellular migration. Loss of 
Dlg1 decreased survival in Apc+/min mice, validating its role as a tumour suppressor 
in the intestine. Significantly the increased survival of Apc+/minKaisoy/- mice was 
shown to be dependent on Dlg1 expression. Taken together this data indicates that 
maintenance of spindle polarity in the intestinal crypt requires appropriate regulation 
of Dlg1 expression. As Dlg1 loss leads to incorrect spindle orientation and a delay in 
cells transiting the intestinal crypt. We propose that the delayed exit from the crypt 
increase the window in which spontaneous mutations can become fixed, producing a 
“tumour-permissive” environment, without an increase in mutation rate. 
Implications: 
Loss of mitotic spindle polarity delays the exit of cells from the intestinal crypt and 
promotes a tumourigenic environment. 
 
Introduction 
Recent work recognising the importance of the link between polarity and epigenetic 
pathways in cancer onset and progression (1) has highlighted a need to increase our 
understanding of these relationships. DNA methylation of CpG dinucleotides is a 
fundamental epigenetic modification. Within gene promoters’ methylation leads to 
transcriptional silencing and is exploited by a range of different cancer types, 
including colorectal cancer, to silence tumour suppressor genes (2,3). There is now 
a growing body of evidence that aberrant epigenetic silencing of polarity genes 
influences tumourigenesis in a variety of settings (4-6). Mechanistically, methylated 
CpG dinucleotides are recognised and bound to by proteins from the methyl binding 
family, which then recruit transcriptional repressor complexes (7). These proteins 
play a key role in disease by identifying tumour suppressor genes that have been 
aberrantly methylated (2,3,8).  The methyl binding protein Kaiso, a POZ/BTB (Broad 
Complex Tramtrak, Bric a brac/pox virus and zinc finger) family zinc finger 
transcription factor protein, has been shown to play a key role in intestinal 
tumorigenesis. POZ/BTB proteins are a well conserved protein family (9) which have 
been indicated to play a role in both development and cancer (10,11). Despite the 
requirement of Kaiso for amphibian development (11), Kaiso null mice are viable and 
do not show any notable abnormalities in either development or reproduction (12). In 
cancer cells Kaiso appears to have a pro-tumourigenic function. Its deficiency 
relieved repression of tumour suppressor and DNA repair genes (13,14) in colon 
cancer. While its nuclear localisation is indicative of higher grade and metastatic 
breast and prostate cancers (15). In addition to its roles as a transcriptional 
repressor it can also bind to δ-Catenin and behave as a transcriptional 
activator(16,17). Further, in vivo studies have shown that Kaiso overexpression 
promotes intestinal inflammation and intestinal tumourigenesis (18,19), while its 
absence increased survival of Apc+/min mice by delaying the onset of intestinal 
tumourigenesis (12). The Apc+/min mouse is a model of the human disease familial 
adenomatous polyposis (FAP). In both Apc+/min mice and FAP patients, mutation of 
the wild-type Apc allele (or ‘second hit’) is required for adenoma formation (20). APC 
mutation and subsequent activation of the canonical Wnt pathway is an early, if not 
the first step, in the development of more than 80% of all sporadic colorectal cancers 
(21,22). Due to its role in mediating epigenetic silencing of tumour suppressor gene 
in human CRC (13) and the low frequency of mutations observed in the disease (0% 
observed in 72 cases (23,24)), Kaiso represents a potentially druggable target. 
However, the mechanism of intestinal tumour suppression due to Kaiso deficiency in 
vivo has yet to be explored.  As the dividing cells in the pre-cancerous and 
cancerous intestinal tissue of Apc+/min mice display alterations to the spindle polarity 
(25) we have investigated whether alterations to spindle polarity play a role in the 
intestinal tumour suppression observed in the Apc+/minKaisoy/- mouse model. We 
have demonstrated that the polarity and tumour suppressor gene Dlg1 is mis-
regulated in the absence of Kaiso. Dlg1 forms part of the Scribble/Lgl/Dlg polarity 
complex, which has been shown to play an important role in the maintenance of 
epithelial integrity (26). Mutations in this complex associated with the progression of 
a range of different epithelial cancer types (27-29) and mutations within the Dlg 
family have been observed in 12 of 72 (16.7%) of colorectal cancer patients (23,24). 
We further demonstrate that the absence of Dlg1 alters spindle polarity, delays 
migration and promotes tumourigenesis and progression in the Apc+/min and 
Apc+/minKaisoy/- setting.  Taken together this increases the evidence demonstrating 
the importance of epigenetic regulation in maintenance of spindle polarity in 
intestinal homeostasis and disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
Mice  
All animal procedures were conducted in accordance with institutional animal care 
guidelines and UK Home Office regulations. Mice were maintained in a SPF barrier 
facility in conventional open top cages on Eco-Pure Chips 6 Premium bedding 
(Datesand, UK) under a 12h light cycle, with IPS 5008 diet (Labdiet-IPS Ltd, UK) 
provided for nutritional support. To enrich environment, we provided irradiated 
sunflower seeds (at weaning only), Techniplast mouse houses (Techniplast, UK) and 
small chewsticks (Labdiet-IPS Ltd, UK). All mice were from a mixed background and 
were homozygous with respect to the C57Bl/6 Pla2g2a (also called Mom-1) allele. 
Experimental animals were between 10-15 weeks old with siblings used as controls. 
The alleles for the Ah-cre(30), Apcflx (31), Apc+/min (32), Villin-Cre (33), Dlg1flx (34), 
Kaisoy/- (12), alleles have been described previously. Genotyping conditions 
available upon request. Induction of the Ah-cre transgene was performed by 
administering 3 intra-peritoneal (I.P.) injections of β-naphthoflavone (BNF; Sigma, 
UK) at 80 mg/kg in a 24-hour period. For BrdU labelling, mice were injected I.P. with 
0.15 mL of BrdU (Amersham, UK). Following cre induction loxP flanked alleles are 
referred to as deleted in intestinal epithelial cells (ΔIEC). 
Microarray Expression Analysis 
Ten-week-old male mice were used for the array analysis. Three mice for each of the 
desired genotypes were used. Three-centimetre portions of the SI located 5cm from 
the stomach were placed in RNAlater (after removing any mesentery and ensuring 
that no Peyer's patches were present). The tissue was then homogenized in Trizol 
reagent and RNA extracted using standard phenol-chloroform methodologies. 
Samples were sent to the Molecular Biology Core facility at the Cancer Research UK 
Molecular Biology Core Facility at The University of Manchester. Where biotinylated 
target cRNA was generated and hybridised to Affymetrix Mouse430A_2 gene 
expression chips. The raw data from these microarrays is available at 
http://www.ebi.ac.uk/arrayexpress/.  The data was normalised and analysed to 
generate differential expression tables using the AffylmGUI package for linear 
modelling of microarray data (35). 
 
Tissue isolation, reporter visualization, immunohistochemistry (IHC) 
Mice were euthanised at specified time points and the small intestine (S.I.) removed 
and flushed with water. Intestines were dissected as follows: The proximal 7 cm was 
mounted, fixed overnight in 10% formalin, and paraffin embedded. The following 3 
cm was opened and placed into RNA later (Sigma), ensuring that all mesentery and 
Peyers patches were removed. The following 5 cm was divided into 1-cm lengths, 
bundled using surgical tape, and then fixed in 4% formaldehyde at 4°C for no more 
than 24 h before processing into wax blocks by conventional means. Section were 
cut at 5 µm thickness, dewaxed, and rehydrated into PBS. Staining was performed 
using the Envision+ mouse or rabbit kit (Dako, Agilent Ltd, Cheshire, UK) according 
to manufacturer’s instructions. To identify cells which had lost Dlg1 we stained using 
a validated rabbit polyclonal anti-Dlg1 antibody (Cat No# STJ111281, St John’s 
Antibodies, London, UK) at 1:200. Cells which had incorporated BRDU were 
identified using an anti-BrdU antibody conjugate (Roche, UK) at 1:50, cells positive 
for DNA damage marker γH2AX were identified using anti-γH2AX (Upstate 05636) 
Cellular analysis was performed on >25 whole crypts from at least three mice of 
each genotype. 
Cellular analysis 
Cellular analysis was performed on >25 whole crypts from at least three mice of 
each genotype. Apoptotic and mitotic index were scored from haematoxylin-and-
eosin-stained sections as previously described (36). The cells between the base of 
the crypt and the junction with the villus was designated as the proliferative zone.  
For migration analysis mice of 60-80 days of age were given an IP injection of BrDU 
2hours or 24hours prior to culling and dissection. Immunohistochemical analysis for 
BrDU incorporation was performed on formalin fixed small intestinal rolls, and the 
number BrDU positive cells and their location (with 0 being the bottom of the crypt) 
was measured on 50 half-crypts per mouse, minimum of 4 mice. Statistical analysis 
of the cumulative frequency of positive cells was performed using a two-tailed 
Kolmogorov-Smirnov test, on graphs P values are indicated as follows: ∗P < 0.05; 
∗∗P < 0.01; ∗∗∗P <0 .001. Measurement of mitotic angle was performed on H&E 
slides stained sections. The angles of 200 mitosis in which the two spindle poles 
were easily observed were measured per mouse, with the angle of a direct line 
drawn between the two spindle poles and the line of the basement membrane 
measured. Measurements of 0˚-45˚ and 135˚-180˚ were classified as “planar”, being 
parallel to the basement membrane, whereas measurements of 45˚-135˚ were 
classified as being “Apico-basal”, being perpendicular to the basement membrane 
and dividing in the orientation of apico-basal polarity. The Chi-squared test was 
performed to assess statistical differences between the two genotypes, on graphs P 
values are indicated as follows: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P <0 .001. 
Chromatin Immunoprecipitation (ChIP) Assay  
ChIP assays were performed to assess Kaiso binding to the promoters of Dlgap1 
and Dlg1 in murine samples from aged Apc+/min mice, using polyps and adjacent 
normal tissue from the small intestine and the large intestine. Anti-Kaiso antibody 
(Santa Cruz, CA, USA, sc-23871) was used to identify DNA binding partners of 
Kaiso, and primers for Dlgap1 and Dlg1 were used to confirm presence of these 
genes (primers detailed in Supplementary Fig 2). 
siRNA against Apc mRNA was purchased from Bioneer (Bioneer, Daejeon, South 
Korea). The Apc siRNA (sense 5’- GCAGGCGUAGAGUAUUCAU -3’, antisense 5’- 
AUGAAUACUCUACGCCUGC -3’) was transfected into CT-26 cells using 
Lipofectamine RNAiMax (Invitrogen, Carlsbad, CA, USA), and knockdown levels of 
were confirmed using qRT-PCR (available upon request). After transfection, the cells 
were harvested, and ChIP analysis performed.  
 
qRT-PCR Analysis 
The following methods were all performed according to manufacturer’s instructions 
unless otherwise stated. For analysis of gene expression in the intestine epithelia, 
three to five mice from each control and experimental group were harvested. RNA 
was extracted from a 0.5 cm portion of small intestine taken ~5 cm distally from the 
stomach and stored at -80 in RNAlater (Sigma, UK).  Total RNA was extracted using 
the RNeasy kit (Qiagen, UK) and DNase treated using the Turbo DNase kit (Ambion, 
UK). Complimentary DNA (cDNA) was transcribed from 1 ug of RNA using random 
hexamers (Promega, UK) and Superscript III (Invitrogen, UK) kits. For relative 
quantitation, all samples were run in duplicate on the StepOnePlus PCR machine 
using Fast Sybr Green master mix (Applied Biosystems, UK). The threshold cycle 
(Ct) values of each gene analysed were normalised to a reference gene. For 
expression analysis (qRT-PCR) Ct values were normalised against the ActB gene. 
Differences between groups were assessed using the 2-∆∆CT method[47]. Two-
tailed Mann-Whitney U (M.W.) tests were performed on the ∆Ct values to determine 
significance (P=<0.05) differences between groups. Oligonucleotide sequences are 
available upon request. 
Survival 
A minimum of 14 mice per cohort were used to assess survival. Mice were aged until 
they showed symptoms of intestinal tumour burden (pale feet, bloating, prolapse or 
piloerection). Survival data was analyzed using the Kaplan-Meier test. If not 
indicated otherwise, the statistical mean is presented, and error bars represent 
standard deviation, on graphs P values are indicated as follows: ∗P < 0.05; ∗∗P < 
0.01; ∗∗∗P <0 .001. 
 
Tumour burden and grading 
Tumour burden was measured at point of death with the number of macroscopic 
lesions and their size from fresh tissue. Grading was performed microscopically 
using H&E slides of small intestine taken from aged mice, tumours were 
microscopically identified as; single crypt lesion (grade 1), microadenoma (grade 2), 
adenoma (grade 3), adenocarcinoma with stromal invasion (grade 4) and 
adenocarcinoma with smooth muscle invasion (grade 5). 
 
Intestinal organoid culture 
Intestinal organoid culture was performed using the method described by Sato et al 
(37). Organoids were grown in Nunc LabTek Chamber Well slides for whole mount 
immunofluorescence. Organoids were fixed overnight in 4% PFA, then 
permeabilised using 1% Triton-X100 for 1hr at 37˚C. Alexa fluor® Phalloidin at 1:150 
and Neomarkers Anti-lysozyme (Rb-327-A1) at 1:300 were used as primary 
antibodies. 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
Apc deficient small intestine crypts are resistant to Kaiso deficiency  
The delayed onset of adenomas in the Apc+/minKaisoy/- mouse is potentially 
due to a role for Kaiso in the Wnt signalling pathway. To investigate the direct effects 
of Kaiso status upon gene expression and Wnt signalling we analysed the phenotype 
of a conditional deletion of Apc in the context of Kaiso deficiency.  Kaisoy/- deficient 
mice were crossed with mice carrying an Ah-cre transgene and a loxP-flanked Apc 
allele, following induction with BNF Apc is deleted in the small intestine (S.I.) crypts. 
We generated and compared cohorts of Ah-cre+ Kaiso+/+ (WT), Ah-cre+ Kaiso-/y 
(Kaiso-/y), Ah-cre+ Apcflx/flx Kaiso+/+(ApcΔIEC/ΔIEC) and Ah-cre+ Apcflx/flx Kaisoy/- 
(ApcΔIEC/ΔIECKaiso-/y) mice. At 4 days post induction (d.p.i.), comparing WT and 
Kaiso-/y indicated the absence of Kaiso does not grossly alter the crypts (Figure 1A 
and B). Similarly the ApcΔIEC/ΔIEC mice, which are characterized by enlarged, aberrant 
crypts (Figure 1C) (as previously reported (38)), appeared unaltered in 
ApcΔIEC/ΔIECKaisoy/− setting (Figure 1D). To examine cell division and migration, mice 
were killed 2hrs or 24hrs after injection with BrdU. BrdU is incorporated into the DNA 
of cells at S phase and is bioavailable for less than 2hrs. Therefore, by killing mice at 
2hrs and 24hrs after exposure, we could track the movement of BrdU-positive cells 
from the proliferation zone in the crypt on to the villus by immunohistochemistry. The 
position of BrdU-positive cells was plotted as the cumulative frequency of cells 2hrs 
and 24hrs after labelling (Figure 1E-H). Migration patterns of the S.I. were not 
significantly altered by the absence of Kaiso, however the data indicated a trend 
towards an increase in the speed of migration of Kaiso deficient cells from the 
proliferative zone onto the villi. In ApcΔIEC/ΔIEC mice cell proliferation occurs 
independently of position and migration of cells along the crypt-villus axis is 
perturbed (Figure 1F), as previously reported (27), the additional loss of Kaiso failed 
to alter this phenotype (Figure 1F).   
Further, it has been previously shown that Paneth cell localisation is altered in 
the induced ApcΔIEC/ΔIEC S.I. (27), the additional loss of Kaiso had no effect on this 
phenotype (Figure 1I). Finally, analysis of Wnt target genes demonstrated that the 
increase in Wnt target gene expression synonymous with Apc deletion was not 
significantly altered in the absence of Kaiso (Figure 1J and Supplementary Figure 1). 
In conclusion, the lack of any gross phenotype in either the Kaisoy/- or the 
ApcΔIEC/ΔIECKaisoy/- mice suggested that repression of intestinal tumourigenesis in the 
Apc+/minKaisoy/- mice is Wnt independent. 
 
The polarity genes Dlg1 and Dlgap1 are upregulated within the Kaiso deficient small 
intestine 
As Kaiso deficiency is well tolerated by the intestine we aimed to identify 
novel roles for Kaiso in the normal and Apc deficient intestine which may influence 
tumourigenesis. To identify genes mis-regulated in the absence of Kaiso, we 
generated microarray gene expression profiles on small intestine from WT and 
Kaiso-/y mice (raw data is available from www.ebi.ac.uk/array express under 
accession number E-MTAB-6009). After normalisation genes differentially expressed 
were identified and ranked according to their statistical significance (Supplementary 
Table 1). As expected the genes Kaiso and Hprt which were deleted in the 
generation of the model were highly down regulated and the most significantly 
altered. As Kaiso is a mediator of epigenetic transcriptional repression we identified 
the genes that were upregulated by its loss and candidates for a role in 
tumourigenesis. The analysis identified the gene Discs Large Homologue Associated 
Protein 1 (Dlgap1) (Supplementary Table 1) which was significantly 4.9-fold up-
regulated in the Kaiso-/y intestine.  Dlgap1 is a highly conserved protein which 
interacts with the guanylate kinase-like domain of the important cancer regulatory 
protein Discs Large Homolog 1 (Dlg1), a binding partner of the key Wnt regulator 
Apc. To support the evidence that these genes are regulated by Kaiso we analysed 
whether the sequence of the promoter regions of these genes contained the Kaiso 
binding sequences TCCTGCNA (minimum binding sequence of CTGCNA) and 
CGCG (39). In silico analysis of the 5kb promoter regions upstream of the Dlg1 and 
Dlgap1 ATG start codons confirmed the presence of 5 minimum Kaiso binding motifs 
and 1 complete Kaiso binding motif in Dlg1 and 1 minimum Kaiso binding motif in the 
Dlgap1 promoter region, indicating its potential to regulate expression of these genes 
(Supplementary Figure 2). To confirm the upregulation of gene expression we used 
QRT-PCR analysis to demonstrate a significant 1.5-fold and 3.3-fold upregulation of 
Dlgap1 and Dlg1 expression, respectively (Figure 2A), in the Kaiso deficient 
intestine. This was further confirmed by immunohistochemistry which showed a 
dramatic increase in Dlg1 protein levels within the intestinal epithelium of Kaiso 
deficient mice (Figure 1B and C). Dlg1 is important in maintenance of spindle polarity 
and is a binding partner of Apc. As spindle polarity is altered in the Apc+/min intestine 
(25), the upregulation of Dlg1 suggested that it may play a functional role in 
suppression of intestinal tumourigenesis and the increased survival of Apcmin Kaiso y/- 
mice.  To confirm a direct role for Kaiso to regulate Dlg1 and Dlgap1 expression 
Chromatin immunoprecipitation (ChIP) was utilised to pull down DNA associated with 
the Kaiso protein in both normal and polyp tissue from the small and large intestine 
of Apcmin mice. Kaiso binding to either Dlgap1 or Dlg1 was not observed in 10 normal 
small intestinal samples or 5 normal large intestinal samples (Fig 2D).  In contrast 
within Apcmin polyps Dlgap1 binding was observed in 3/10 small intestinal tumours 
and 3/5 colonic polyps, with Dlg1 binding observed in 1/10 small intestinal tumours 
and 3/5 colonic polyps (Fig 2D). These data indicate that Kaiso has the ability to bind 
to Dlgap1 and Dlg1, but does so only an Apc deficient environment. To confirm this 
finding, ChIP was also used to assess Kaiso binding to Dlgap and Dlg1 in the mouse 
colon carcinoma cell line CT-26 in which Apc is intact.  Using siRNA methods to 
generate a greater than 8 fold knock-down Apc (Figure 2E), demonstrated that 
binding of Kaiso to the promoters of Dlgap1 and Dlg1 was significantly increased in 
the in an Apc deficient setting. (Figure 2F).  Taken together this data indicates that 
regulation of expression of Dlgap1 and Dlg1 in the normal intestine is most likely 
indirect, however in a tumour permissive environment, Kaiso can directly bind to the 
promoters and regulate expression. 
 
Dlg1 loss disrupts cell division polarity and migration rates in intestine 
Dlg1 is known to regulate cell polarity and is a key part of the scribble/dlg/lgl 
polarity complex (40) and the Apc destruction complex. To investigate the role of 
Dlg1 in the intestine we analysed villin-creDlg1flx/flx mice (34), in which exon 4 of the 
Dlg1 gene is flanked by LoxP and driven by endogenous expression of Cre from the 
Villin promoter to initiate loss of Dlg1 at embryonic E9 within the intestinal epithelium 
(41). Survival analysis was performed by aging cohorts of villin-cre Dlg1+/+ (WT) and 
villin-cre Dlg1flx/flx (Dlg1ΔIEC/ΔIEC) mice. Overall there was no significant difference in 
survival between WT and Dlg1ΔIEC/ΔIEC and at death the intestinal epithelium of 
Dlg1ΔIEC/ΔIEC mice appeared functionally normal (Figure 3A).  Histological 
assessment of Dlg1ΔIEC/ ΔIEC intestinal tissue revealed that Dlg1 deficiency does not 
alter crypt length (number of cells), apoptosis (number of apoptotic bodies) or 
proliferation (Supplementary Figure 3 A, B and C). In summary, it appears that Dlg1 
loss is well tolerated by the intestinal epithelium and alone is not sufficient to induce 
colorectal tumourigenesis. As Dlg1 is known to form part of the important 
Scribble/Lgl/Dlg polarity complex, we next explored the role of these gene in the 
Dlg1 deficient intestine. Expression qRT-PCR analysis of the polarity genes 
associated with Dlg1 indicated a significant reduction in expression of the Scribble 
(Scrib1) gene which forms part of the polarity complex) (Figure 3B).  The lack of any 
gross phenotype as a result of loss of Dlg1 and significant reduction in Scrib 
expression suggested that other cues from the extracellular matrix (ECM) or 
redundancy amongst Dlg family members may compensate for the absence of Dlg1 
in order to maintain the correct architecture of the intestinal epithelia in vivo (42). 
However, further investigation revealed no expressional compensation by other Dlg 
family member genes (supplementary Figure 4), indicating that extremely low levels 
of Dlg1 expression as observed in the Dlg1ΔIEC/ ΔIEC model are sufficient to maintain 
intestinal crypt morphology. 
To investigate the role of Dlg1 loss on polarity, specifically within the intestinal 
epithelium in the absence of ECM cues, small intestinal organoid cultures were 
made from both WT and Dlg1ΔIEC / ΔIEC tissue. Whole mount immunofluorescence for 
the marker of the apical tip/ brush border of intestinal epithelial cells revealed no 
obvious cell polarity defects as a result of Dlg1 deficiency within the intestinal 
epithelium (Figure 3C & D). As well as playing a key role in maintaining normal apical 
basal polarity Dlg1 has a role in spindle orientation during mitosis. Within the WT 
crypt 86% of cell divisions occurred in a “planar” orientation, with mitotic spindles 
running parallel to the basement membrane while the remaining 14% of mitotic 
spindles occurred in a “apico-basal” direction (Figure 3E). Analysis of the 
Dlg1ΔIEC/ΔIEC intestine demonstrated a significant shift in spindle orientation to 79% 
planar to 21% apico-basal(Figure 3F;Chi-squared test P=0.0437). As planar cell 
divisions are in line with normal migration along the crypt villus axis any alterations 
may lead to delayed exit of cells from the crypt. Further BrDU analysis at a 2h time 
point indicated that Dlg1 deficiency did not alter the position of cells undergoing 
mitosis (Figure 3G). However, at 24h the Dlg1 deficient BrDU+ cells were 
significantly lower down the crypt-villus axis compared to wild type controls (Figure 
3G; (Kolmogorov-Smirnov p<0.0001). Potentially the delay in Dlg1 deficient cells 
exiting the crypt may impact on tumourigenesis as it could increase the time for 
oncogenic mutations to become fixed, creating a tumour-permissive environment. 
Levels of cell DNA mutation within the intestine were assessed by qRT-PCR for a 
range of DNA repair pathway genes, and the protein localisation of the DNA damage 
marker γH2AX  was assessed by immunohistochemistry and counted, showing no 
difference (supplementary Fig 5).This was expected as it is not thought that the rate 
of mutation is controlled by Dlg1, simply the rate at which mutated cells migrate. 
Dlg1 loss promotes intestinal tumourigenesis in Apc+/min mice 
To explore the role of Dlg1 in intestinal tumourigenesis VillinCre+ Dlg1flx/flx 
mutant mice were crossed with Apc+/min mice to generate Apc+/min and Apc+/min 
VillinCre+ Dlg1fl/fl (ApcminDlg1 ΔIEC/ΔIEC) cohorts. To confirm our previous finding for the 
role of Dlg1 in spindle orientation we repeated the analysis on the normal crypts in 
these mice. As predicted we observed a significant increase in apico-basal mitotic 
spindles from 14% in WT (Figure 3E) to 19% in Apc+/min (Figure 4A; Chi-squared test 
P<0.001) to 32% in Apc+/minDlg1ΔIEC/ΔIEC mice (Figure 4B; Chi-squared test P>0.001). 
The mice were aged and harvested until they reached a humane endpoint indicating 
an intestinal tumour burden. Survival analysis indicated a significant decrease in 
survival of ApcminDlg1ΔIEC/ΔIEC in comparison to Apc+/min mice (Figure 4C, Log-
Rank(Mantel-Cox) P=0.0309). At point of harvest there was no significant difference 
to the total median tumour burden between the cohorts, indicating mice were 
analysed at equivalent stages (Figure 4D). However, it was noted that even though it 
did not achieve statistical significance the median number of tumours in the small 
intestine increased from 17 in the Apc+/min mice to 30 in the ApcminDlg1ΔIEC/ΔIEC cohort 
(Figure 4E), with the ApcminDlg1ΔIEC/ΔIEC mice showing a significant increase in inter-
mouse variability. To understand why ApcminDlg1ΔIEC/ΔIEC reached the endpoint 
sooner than Apc+/min mice, we examined the grade of tumours in the mice, as loss of 
spindle polarity is associated with EMT and progression. Microscopic grading of the 
observed lesions identified a significant increase in the transition of single crypt 
lesions to more advance tumour types, including adenocarcinomas with stromal and 
smooth muscle invasion rarely observed in the Apcmin mice (Figure 4G). In 
conclusion, the data indicates that that Dlg1 acts as a tumour suppressor in the 
murine intestine by preventing loss of spindle polarity, supporting cell migration rates 
and preventing progression of lesions. 
Tumour suppression due to Kaiso deficiency is Dlg1 dependent 
Previously we reported that loss of Kaiso suppressed tumourigenesis in the Apc+/min 
model. Here we have identified that Dlg1 is upregulated in the Kaiso null intestinal 
epithelium and acts as a tumour suppressor in the Apc+/min model. To assess if the 
increased survival of Apcmin Kaisoy/- mice is dependent on the presence of a 
functional Dlg1 gene and/or related to spindle polarity, we generated Apcmin Kaisoy/-
Dlg1ΔIEC/ΔIEC mice.  Analysis of spindle polarity indicated that the proportion of 
aberrantly orientated spindles was significantly reduced from 19% in the Apc+/min  
mice to 12% in the Apcmin Kaiso-/- (Figure 5Aand B; Chi-squared test P<0.001). A 
similar level to the WT setting (Figure 3E) and a potential reason for the subtle 
increase in cell migration from villus to crypt (Figure 1E). We next examined the 
Apc+/min Kaiso-/-Dlg1flx/flx mice and demonstrated that the improvement in percentage 
of mis-orientated divisions due to Kaiso loss was lost with the additional absence of 
Dlg1 (Figure 5A and B; Chi-squared test P<0.001). Significantly there was no 
difference in the percentage of aberrant mitosis in the apico-basal orientation 
between the ApcminDlg1ΔIEC/ΔIEC and Apcmin Kaisoy/-Dlg1ΔIEC/ΔIEC intestines (Figure 
5A), and no change in total levels of cell proliferation between the cohorts (Figure 
5C).  To investigate whether the improvement in the proportion of mitotic spindles in 
the planar orientated in Apc+/min Kaisoy/- intestine was important in the tumour 
suppression we generated cohorts of Apcmin Kaisoy/-Dlg1ΔIEC/ΔIEC mice and aged until 
humane endpoint was reached. As previously observed the loss of Kaiso increased 
survival (Figure 5D; Apc+/min Kaisoy/- mice were only aged to 200 days to confirm 
increased survival and then sacrificed). As reported earlier (Figure 4C) there is a 
significant decrease in survival of of Apcmin Dlg1ΔIEC/ΔIEC which was not rescued by 
the additional loss of Kaiso (Figure 5D). Further the increased aggression of lesions 
observed in ApcminDlg1ΔIEC/ΔIEC again presented in the Apcmin Kaisoy/-Dlg1ΔIEC/ΔIEC 
(Figure 5E). In conclusion, this data suggests that the tumour resistance observed in 
the intestine ApcminKaisoy/- mice requires expression of the Dlg1 gene. We propose 
that the appropriate expression of Dlg1 prevents mitosis occurring at an aberrant 
apico-basal orientation, maintains the rates of cell migration onto the villus and 
therefore may decrease the window of opportunity for tumourigenesis (Figure 6). 
  
 
  
Discussion 
In summary, here we have demonstrated that in the absence of the epigenetic 
regulator Kaiso there is an increase in expression of the polarity proteins Dlg1 and 
Dlgap1. The absence of Dlg1 results in an increase in the number of baso-lateral cell 
divisions within the intestinal crypt and a decrease in cell migration rates. On the 
Apc+/min background the absence of Dlg1 decrease survival due to an increase in the 
number and aggressiveness of tumours. Further the loss of Dlg1 overcomes the 
suppression of intestinal tumorigenesis observed in the Apc+/minKaiso-/y mouse 
model.  Suggesting that the mechanisms that maintain planal mitotic orientation and 
migration rates have important anti-tumourigenic roles. Although there are many 
potential mechanisms for the control of migration rates along the crypt-villus axis, 
including cell:cell signalling and negative draw of cells through the sloughing of cells 
at the villus tip, there is much evidence to support the concept that mitosis supports 
normal cellular migration along the crypt villus axis through mitotic pressure (43,44). 
This leads to the assumption that the angle of mitosis within the crypt could play a 
part in normal migration patterns. The rapid cell migration along the crypt-villus axis 
is one of the driving factors which controls the quick turn over of cells within the 
intestinal epithelium and is essential to minimise the risk of tumourigenesis. It 
achieves this by flushing undetected mutant cells from the epithelium before they 
can disrupt intestinal homeostasis. Through delayed migration it can be 
hypothesised that Apc+/min cells which have lost the wild type copy of Apc (through 
random mutations, loss of heterozygosity or epigenetic silencing) may remain within 
the intestinal epithelium for a longer period of time, increasing the opportunity for 
lesion formation. An alternative hypothesis is that the increased crypt residence time 
of a cell increases the likelihood that it will accumulate additional oncogenic 
mutations e.g. K-ras, Smad4 or p53. This may account for the increased 
aggressiveness of the tumours observed in the Apc+/min Dlg1-/- model. The role of cell 
migration speed within the intestinal epithelium in creating a tumour permissive 
environment has been hypothesised elsewhere (45,46), and in fact many previously 
established chemo-preventative agents play a role in increasing cellular migration 
(47), which may contribute to their efficacy in delaying tumour onset.  
Normal planar cell divisions within the crypt can support mitotic pressure for 
migration to occur in a straight line, the quickest route from crypt base to villus tip, 
whereas apico-basal divisions could logically result in “side-to-side” cell movement 
as well as “upward”, which could be responsible for the increased migration time 
observed in Dlg1ΔIEC / ΔIEC mice (Figure 6). This has been previously shown in 
astrocyte cells in which deficiency of the Dlg1:Dlgap1 complex, also identified in this 
study, leads to inefficient migration(40). Further, while severely abnormal angles of 
mitosis may lead to delamination of cells they would normally undergo apoptosis. 
Any further suppression of apoptosis leads to formation of disorganised masses of 
aberrant cells with characteristics of tumorigenesis and EMT, potentially accounting 
for the increase in more advanced lesion observed here. However, it must be noted 
that during mitosis within the intestinal crypt, cells step out of the epithelial sheet but 
maintain contact with surrounding cells and divide more luminally before the 
daughter cells return to the intestinal epithelium proper. It is possible that the 
orientation of cell division makes less difference to the final position of the daughter 
cells within the intestinal epithelium than the process by which cells return to the 
epithelial sheet. 
Previous reports have linked epigenetic modification to altered expression of 
genes associated with cell polarity (48), thereby enabling transcriptional repressors 
such as Kaiso to regulate cell polarity. However further work using chromatin 
immuno-precipitation techniques is required to confirm that these genes are direct 
targets of Kaiso. The work we present here supports the idea that transcriptional 
repression of polarity associated genes plays a role in tumourigenesis and tumour 
invasion (49), and that inhibition of such epigenetic regulators may be of therapeutic 
value. However, it should be noted that the phenotype associated with the loss of 
Kaiso may also reflect yet unidentified changes in genes associated with its 
transcriptional activation functions. At the very least, identification and exploration of 
the targets of such epigenetic transcriptional regulators which may influence cell 
polarity could prove to be of value to the field of cancer research. As Kaiso inhibition 
has been suggested as a potential therapeutic strategy for the treatment of colorectal 
cancer, and inhibitors for this transcriptional repressor are currently being 
investigated (50). The work presented here indicates that the tumour-suppressive 
effect of Kaiso loss is limited to systems in which functional Dlg1 is present at the 
initiation stage of a tumour. It remains to be determined whether targeting Kaiso in a 
higher-grade tumour will have any beneficial effect and whether it would be 
dependent on Dlg1 remaining unmutated within the patient’s tumour. As such, the 
efficacy of such a treatment would be limited to lower grade tumours where Dlg1 
remains functional, and tumour resistance to treatment could develop through 
additional mutations in Dlg1. 
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Figure legends 
Fig. 1. Loss of Kaiso does not alter the gross phenotype of WT and Apc deficient SI 
crypts. Haematoxylin and eosin staining showing no difference between WT (A) and 
Kaiso-/y (B) or Ah-cre Apc∆IEC/∆IEC (C) and Ah-creApcΔIEC / ΔIEC Kaiso-/y (D) S.I., note 
the enlarged crypts in the Apc∆IEC/∆IEC mice are retained in Apc∆IEC/∆IECKaiso-/y ([ 
indicates height of crypts), Scale bars represent 50µm. (E & F) Mice were injected 
with BrdU to mark cells in S phase at 2h and track migration onto villi 24h later. (E)  
WT 2h (), Kaiso-/y 2h (---), WT 24h (⋅⋅⋅), Kaiso-/y 24h (-⋅-⋅) and (F) ApcIEC/IEC 2h 
(), Apc∆IEC/∆IEC Kaiso-/y 2h (---), Apc∆IEC/∆IEC 24h (⋅⋅⋅), Apc∆IEC/∆IEC Kaiso-/y 24h (-⋅-⋅) 
BrdU-positive cells indicated no alteration to the position and size of the proliferative 
zones or rate of migration (absent in the Apc∆IEC/∆IEC S.I.), n≥4, with representative 
images of 24hr BrDU in WT and Kaiso-/y small intestine (G & H), scale bar represents 
50µm. (I) The absence of Kaiso does not alter the normal position of Paneth cells or 
rescue their mis-localisation in the Apc∆IEC/∆IEC S.I; WT (), Kaiso-/y (---), Apc∆IEC/∆IEC 
(⋅⋅⋅) and Apc∆IEC/∆IEC Kaiso-/y (-⋅-⋅), n≥4. (J) Relative expression analysis indicated no 
significant alteration to Wnt target genes in the absence of Kaiso (WT-black, Kaiso-/y-
white, Apc∆IEC/∆IEC -dark grey and Apc∆IEC/∆IEC Kaiso-/y-light grey), error bars indicate 
standard deviation, n≥4 
Fig. 2. Upregulation of Dlg1 and Dlgap1 in the Kaiso deficient intestine. (A) qRT-
PCR analysis indicating down regulation of Kaiso and up regulation of Dlg1 and 
Dlgap1 in the Kaiso-/y intestine (WT-black bars; Kaiso-/y - grey bars), error bars 
indicate standard deviation, n≥4. Immunohistochemistry comparing WT (B) to Kaiso-
/y small intestine(C) demonstrating an increase in Dlg1 staining in the intestinal 
epithelial of the Kaiso deficient intestine, scale bar represents 100µm. ChiP analysis 
was used to assess the ability of Kaiso to bind Dlgap1 and Dlg1 in murine small 
intestine, large intestine, small intestinal polyps and large intestinal polyps (D), Apc 
SiRNA enabled a more than 8 fold knock down of Apc within the murine cell line CT-
26 (E), and ChIP analysis was used to assess the ability of Kaiso to bind  to Dlgap1 
and Dlg1 when CT-26 cells were treated with either control scrambled siRNA (light 
grey) or Apc siRNA (dark grey) (F), Error bars represent standard deviation.   
Fig. 3. Absence of Dlg1 is tolerated by the S.I. but disrupts mitotic spindle orientation 
and migration. (A) Kaplan-Meier survival analysis of aged WT () and vilCre-
Dlg1∆IEC/∆IEC (…) cohorts indicates no difference in overall survival. (B) Scrib is 
significantly (Mann-Whitney; P=0.002) downregulated in the Dlg1∆IEC/∆IEC intestine, 
error bars indicate standard deviation, n≥4. (C & D) Whole mount 
immunofluorescence of WT (C) and Dlg1∆IEC/∆IEC (D) organoids demonstrating the 
maintenance of cellular polarity (green-phalloidin, red-lysozyme expression and blue-
DAPI). Analysis of mitotic angles in WT (E) and Dlg1∆IEC/∆IEC (F) indicates a 
significant decrease in divisions occurring in a planar orientation (white segments; E 
right panel red circle indicating planal mitosis) and an increase in apico-basal 
divisions (grey segments; F right panel red circle indicating apico-basal mitosis) as a 
result of Dlg1 deficiency, n≥6. (G) Comparison of the position of BrdU+ cells at 2h 
() and 24h (…)in WT (black) and Dlg1∆IEC/∆IEC (grey) indicating a delay in migration 
in the Dlg1∆IEC/∆IEC crypt (Kolmogorov-Smirnov test p<0.0001), with representative 
images of 24hr BrDU, n≥4 (H&I). 
Fig. 4. Dlg1 is a tumour suppressor in the murine intestine. Analysis of mitotic 
spindle angles in crypts of Apc+/min (A) and Apc+/minDlg1∆IEC/∆IEC (B) crypts indicates 
loss of Dlg1 leads to a significant decrease in the proportion of cells dividing in a 
normal planar orientation (Chi-squared test P>0.001; grey). (C) Kaplan-Meier 
analysis demonstrating a significant reduction in overall survival of 
Apc+/minDlg1∆IEC/∆IEC (black line) mice compared to Apc+/min (Grey line)(Log-rank 
(Mantel-Cox) P=0.0309). The total number of tumours (D) and their burden (E) were 
not significantly altered in Apc+/minDlg1∆IEC/∆IEC mice, although they both displayed an 
increased inter mouse variability (Levene’s test for equality of variances p=0.018). 
(F) Lesions observed within Apc+/minDlg1∆IEC/∆IEC (black bars) small intestine at end 
point were significantly more severe than those observed in Apc+/min (grey bars, error 
bars indicate standard deviation)(Chi-squared test). SI= Stromal Invasion, SMI= 
smooth muscle invasion, n≥28 lesions counted from 4mice. (G) Lesion from an 
Apc+/minDlg1∆IEC/∆IEC mouse indicating progression of tumour to adenocarcinoma with 
submucosal () and smooth muscle invasion (), scale bar represents 500µm. 
Fig. 5. The Kaiso deficient intestine requires an intact Dlg1 to manifest its tumour 
resistance. (A) The proportion of aberrantly orientated mitotic spindles is significantly 
reduced in the Apc+/minKaisoy/- but increased in the Apc+/minDlg1∆IEC/∆IEC,  and 
Apc+/minKaisoy/-Dlg1∆IEC/∆IEC, when compared to Apc+/min intestine. Statistics were 
performed using Mann Whitney, * indicates p≤0.05, n≥6. (B) Representative images 
of Apc+/min, Apc+/minDlg1∆IEC/∆IEC , Apc+/minKaisoy/- and Apc+/minKaisoy/-Dlg1∆IEC/∆IEC 
intestine, with indicated aberrant apico-basally orientated cell divisions(←) and 
planar cell divisions (↑) Scale bars represent 100µm. BrDU analysis (C) indicated 
there were no differences in total levels of proliferation within the intestine, n≥4. (D) 
Kaplan-Meier survival analysis demonstrating a decreased survival of Apc+/min∆IEC/∆IEC 
(grey dotted line) and Apc+/minKaisoy/-Dlg1∆IEC/∆IEC (grey solid line; Log-rank (Mantel-
Cox) P=0.0441) compared to Apc+/min (black solid) and Apc+/minKaisoy/-(black dashed) 
mice, vertical mark indicate mouse disease free survival n≥9. (E) Adenocarcinoma 
with sub-mucosal invasion (←)( from an Apc+/minKaisoy/-Dlg1∆IEC/∆IEC mouse, scale 
bar represents 500µm. 
Fig. 6. Model of tumour suppression by Dlg1. (A) In the normal intestine Dlg1 plays 
an important role in maintaining the planal orientation of mitosis to ensure that 
division occurs in the same direction as migration. (B) In the Dlg1 deficient intestine 
alteration to the angles of mitosis conflict with the direction of cell migration leading 
to longer transit times from the crypt-base to the villus. Potentially increasing the 
window of opportunity for fixation of a mutant cell, which may then migrate in multiple 
directions and increasing the chance of invasion into the sub-mucosa. 
Supplementary Information Legends 
Supplementary Fig. 1. Relative expression analysis indicated no significant 
alteration to Wnt target genes expression in the intestine of the Kaiso deficient 
mouse. Graph of the dCt values for the fold expression change data in Fig. 1. 
Supplementary Fig. 2. (A&B) Dlg1 and Dlgap1 promoter regions contain Kaiso 
binding sequences. The region 5kb upstream of the Dlg1 exon 1 (NR_045516) and 
Dlgap1 (NM_177639), Kaiso binding domains ((full -TTCCTGCNA (red) & minimum-
CTGCNA (green)) and CGCG (blue). Primers locations used for ChIP analysis are 
indicated in yellow. 
Supplementary Fig. 3. The loss of Dlg1 is tolerated by the small intestinal 
epithelium. Comparing WT and Dlg1∆IEC/∆IEC at death indicated there were no 
significant changes in (A) cellular height of crypt, number of apoptotic (B) and mitotic 
(C) bodies per 50 half crypts. 
Supplementary Fig. 4. Intestinal samples from Dlg1∆IEC/∆IEC (black bars) show 
significantly reduced Dlg1 expression compared to Wildtype (grey bars), but there is 
no significant changes in expression levels of other Dlg family members. 
Supplementary Fig. 5 qRT PCR analysis indicated that Dlg1 deficiency within the 
intestinal epithelium resulted in no significant change in expression levels of a range 
of DNA repair genes which are associate with the 5 main DNA repair pathways, as 
indicated (A), with immunohistochemical analysis for the DNA damage marker 
γH2AX showing no significant difference between WT and Dlg1ΔIEC/ΔIEC crypts (B).  
Supplementary Table 1. Top 50 differential expressed genes in the Kaiso-/y intestine 
versus WT. 
